Related Experiment Video
Updated: May 27, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Diagnostic criteria and laboratory tests for disseminated intravascular coagulation
1Department of Patient Safety and Infectinon Control, Mie University Graduate School of Medicine, Tsu, Japan.
Insights
Disseminated intravascular coagulation (DIC) is a fatal condition often linked to organ failure. Early diagnosis and treatment using hemostatic markers are crucial for improving patient outcomes.
Area of Science:
- Hematology
- Critical Care Medicine
Background:
- Disseminated intravascular coagulation (DIC) is a life-threatening condition associated with organ failure, frequently stemming from infections, hematological malignancies, or solid cancers.
- DIC presents in two forms: overt and non-overt.
- Established diagnostic criteria by the International Society on Thrombosis and Haemostasis (ISTH) and the Japanese Association for Acute Medicine (JAAM) aim to standardize diagnosis.
Purpose of the Study:
- To review the current understanding of Disseminated Intravascular Coagulation (DIC) diagnosis and treatment.
- To highlight the importance of early detection and intervention in managing DIC.
- To discuss potential therapeutic advancements for improving DIC mortality rates.
Main Methods:
- Review of existing literature on DIC diagnostic criteria, including ISTH and JAAM guidelines.
- Analysis of the mechanisms underlying DIC development, focusing on factors like tissue factor and cytokines.
- Examination of current and emerging treatment strategies, including novel therapeutic agents.
Main Results:
- The JAAM diagnostic criteria show high sensitivity for predicting mortality in DIC but lack specificity.
- Mechanisms of DIC onset are diverse, influenced by underlying pathologies and biological factors.
- Hemostatic molecular markers are essential for early and accurate DIC diagnosis.
Conclusions:
- Early diagnosis and prompt treatment are critical for improving outcomes in patients with DIC.
- Emerging therapies such as recombinant activated protein C and recombinant thrombomodulin show promise in reducing DIC mortality.
- Further research is necessary to develop improved diagnostic and therapeutic approaches for DIC.
Abstract:
Disseminated intravascular coagulation (DIC) is associated with organ failure and it is often fatal condition. The main underlying diseases are infection, hematological malignancy and solid cancer. DIC is subclassified into overt DIC and non-overt DIC. The International Society on Thrombosis and Haemostasis (ISTH) and the Japanese Association for Acute Medicine (JAAM) published the diagnostic criteria for DIC after several recent clinical trials. These diagnostic criteria are modified versions of the Japanese Ministry of Health, Labor and Welfare (JMHLW) criteria. The JAAM diagnostic criteria demonstrated excellent sensitivity for mortality but low specificity. The mechanisms of onset of DIC vary based on the underlying diseases, and depend on tissue factor, cytokines, etc. Early diagnosis and early treatment for DIC are important, and the use of hemostatic molecular markers is necessary to successfully make an early and rapid diagnosis. The mortality of DIC might be improved by the administration of recombinant activated protein C or recombinant thrombomodulin. Further investigation to improve the mortality of DIC is required, including new methods for diagnosing and treating the disease.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
